Feasibility of balloon rectal spacer implantation in HDR and LDR brachytherapy for prostate cancer treatment.

Brachytherapy Pub Date : 2025-01-01 Epub Date: 2024-11-10 DOI:10.1016/j.brachy.2024.10.003
Tomer Charas, Salem Billan
{"title":"Feasibility of balloon rectal spacer implantation in HDR and LDR brachytherapy for prostate cancer treatment.","authors":"Tomer Charas, Salem Billan","doi":"10.1016/j.brachy.2024.10.003","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the use of a biodegradable balloon rectal spacer in two prostate cancer patients undergoing low dose radiation (LDR) and salvage high dose radiation (HDR) brachytherapy. The spacer aims to reduce radiation dose to adjacent organs, particularly the rectum, in patients previously treated with radiation.</p><p><strong>Methods: </strong>The balloon spacer was implanted transperineally under transrectal ultrasonography (TRUS) guidance in two patients. For the LDR case (73-year-old, intermediate-risk), the balloon was placed postimplant with 55 iodine-125 seeds delivering 145 Gy. For the HDR case (66-year-old, high-risk), the balloon was placed one week before treatment, which delivered 23 Gy in two weekly fractions using 16 channels.</p><p><strong>Results: </strong>The balloon provided a 14-15mm separation between rectum and prostate. In the LDR case, prostate D90 was 149.1Gy (102.83%), V100 was 91.95%, and rectum D30 was 23.93Gy (16.50%). For the HDR case, prostate D90 was 11.63Gy (105.79%), V100 was 93.63%, and rectum D0.5cc was 8.04Gy (73.15%). Both patients tolerated the treatment well, with no observed postoperative complications at 6-month follow-up.</p><p><strong>Conclusions: </strong>The use of a rectal balloon spacer in both salvage HDR and LDR brachytherapy is feasible and safe, allowing for controlled placement and providing rectal protection from high radiation doses.</p>","PeriodicalId":93914,"journal":{"name":"Brachytherapy","volume":" ","pages":"186-189"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brachytherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.brachy.2024.10.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study evaluates the use of a biodegradable balloon rectal spacer in two prostate cancer patients undergoing low dose radiation (LDR) and salvage high dose radiation (HDR) brachytherapy. The spacer aims to reduce radiation dose to adjacent organs, particularly the rectum, in patients previously treated with radiation.

Methods: The balloon spacer was implanted transperineally under transrectal ultrasonography (TRUS) guidance in two patients. For the LDR case (73-year-old, intermediate-risk), the balloon was placed postimplant with 55 iodine-125 seeds delivering 145 Gy. For the HDR case (66-year-old, high-risk), the balloon was placed one week before treatment, which delivered 23 Gy in two weekly fractions using 16 channels.

Results: The balloon provided a 14-15mm separation between rectum and prostate. In the LDR case, prostate D90 was 149.1Gy (102.83%), V100 was 91.95%, and rectum D30 was 23.93Gy (16.50%). For the HDR case, prostate D90 was 11.63Gy (105.79%), V100 was 93.63%, and rectum D0.5cc was 8.04Gy (73.15%). Both patients tolerated the treatment well, with no observed postoperative complications at 6-month follow-up.

Conclusions: The use of a rectal balloon spacer in both salvage HDR and LDR brachytherapy is feasible and safe, allowing for controlled placement and providing rectal protection from high radiation doses.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在前列腺癌的 HDR 和 LDR 近距离放射治疗中植入球囊直肠垫片的可行性。
目的:本研究评估了生物可降解球囊直肠垫片在两名接受低剂量放射治疗(LDR)和挽救性高剂量放射治疗(HDR)近距离放射治疗的前列腺癌患者中的应用情况。该垫片旨在减少曾接受过放射治疗的患者邻近器官(尤其是直肠)的放射剂量:方法:在经直肠超声(TRUS)引导下,经会阴部为两名患者植入了球囊垫片。在 LDR 病例(73 岁,中危)中,球囊植入后放置了 55 颗碘-125 粒子,放射剂量为 145 Gy。对于 HDR 病例(66 岁,高风险),球囊在治疗前一周放置,使用 16 个通道,每周分两次释放 23 Gy:球囊在直肠和前列腺之间提供了 14-15 毫米的间隔。在 LDR 病例中,前列腺 D90 为 149.1Gy(102.83%),V100 为 91.95%,直肠 D30 为 23.93Gy(16.50%)。在 HDR 病例中,前列腺 D90 为 11.63Gy(105.79%),V100 为 93.63%,直肠 D0.5cc 为 8.04Gy(73.15%)。两名患者对治疗的耐受性良好,术后 6 个月随访时未观察到并发症:在抢救性 HDR 和 LDR 近距离放射治疗中使用直肠球囊垫片既可行又安全,既能控制放置位置,又能保护直肠免受高辐射剂量的伤害。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
From patient to pioneer: The inspiring journey of Dr. Brian Moran. Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study. A retrospective study on ruthenium-106 and strontium-90 eye-plaques treatment for retinoblastoma: 16-years clinical experience. The influence of time and implants in high-dose rate image-guided adaptive brachytherapy for locally advanced cervical cancer. Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprostatic recurrences.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1